|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/48 | (2006.01) |
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 2279007 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09738181.8 |
| Date of filing the European patent application | 2009-04-29 | |
| (97) | Date of publication of the European application | 2011-02-02 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-18 |
| (46) | Date of publication of the claims translation | 2016-10-10 |
| (86) | Number | PCT/EP2009/055194 |
| Date | 2009-04-29 |
| (87) | Number | WO 2009/133137 |
| Date | 2009-11-05 |
| (30) | Number | Date | Country code |
| 08155408 | 2008-04-29 | EP | |
| 08162865 | 2008-08-22 | EP | |
| 08167289 | 2008-10-22 | EP |
| (72) |
RAU, Harald, DE
KINDERMANN, Susanne, CH
LESSMANN, Torben, DE
RASMUSSEN, Grethe Norskov, DK
HERSEL, Ulrich, DE
WEGGE, Thomas, DE
SPROGOE, Kennett, US
|
| (73) |
Ascendis Pharma Endocrinology Division A/S,
Tuborg Boulevard 5, 2900 Hellerup,
DK
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pegiliuoto rekombinantinio žmogaus augimo hormono junginiai |
| PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2025-04-16 | 17 | 347.00 EUR |
| 2026-04-29 |